Literature DB >> 1374051

Structure of the gene encoding CD34, a human hematopoietic stem cell antigen.

A B Satterthwaite1, T C Burn, M M Le Beau, D G Tenen.   

Abstract

CD34 is a cell surface antigen of unknown function expressed in humans in hematopoietic stem cells, vascular endothelium, and blasts from 30% of patients with acute myeloid and lymphocytic leukemia. To begin to investigate the cis-acting elements required for this tissue-specific expression, the human CD34 locus was isolated and its genomic structure and transcriptional start site were characterized. The human CD34 gene spans 26 kb and has 8 exons, a structure quite similar to that of the murine gene. The start site of CD34 transcription was determined to be 258 bp upstream of the translational start site using RNase protection. These experiments also indicated that the 5' untranslated region has extensive secondary structure. In addition, fluorescence in situ hybridization was used to map the CD34 locus to band 1q32.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1374051     DOI: 10.1016/0888-7543(92)90310-o

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  32 in total

1.  The transcriptome of human CD34+ hematopoietic stem-progenitor cells.

Authors:  Yeong C Kim; Qingfa Wu; Jun Chen; Zhenyu Xuan; Yong-Chul Jung; Michael Q Zhang; Janet D Rowley; San Ming Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-30       Impact factor: 11.205

2.  Converting stem cells to dendritic cells by agonist antibodies from unbiased morphogenic selections.

Authors:  Kyungmoo Yea; Hongkai Zhang; Jia Xie; Teresa M Jones; Guang Yang; Byeong Doo Song; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-26       Impact factor: 11.205

Review 3.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

4.  A preliminary gene map for the Van der Woude syndrome critical region derived from 900 kb of genomic sequence at 1q32-q41.

Authors:  B C Schutte; B C Bjork; K B Coppage; M I Malik; S G Gregory; D J Scott; L M Brentzell; Y Watanabe; M J Dixon; J C Murray
Journal:  Genome Res       Date:  2000-01       Impact factor: 9.043

5.  Reduced bone marrow stem cell pool and progenitor mobilisation in multiple myeloma after melphalan treatment.

Authors:  L M Knudsen; T Rasmussen; L Jensen; H E Johnsen
Journal:  Med Oncol       Date:  1999-12       Impact factor: 3.064

6.  Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells.

Authors:  C Vitale; C Romagnani; M Falco; M Ponte; M Vitale; A Moretta; A Bacigalupo; L Moretta; M C Mingari
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 7.  Therapeutic Advancement in Neuronal Transdifferentiation of Mesenchymal Stromal Cells for Neurological Disorders.

Authors:  Princy Choudhary; Ayushi Gupta; Sangeeta Singh
Journal:  J Mol Neurosci       Date:  2020-10-13       Impact factor: 3.444

Review 8.  Functions of stem cells of thyroid glands in health and disease.

Authors:  Ebtesam A Al-Suhaimi; Khulood Al-Khater
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

9.  Establishment and characterization of a novel CD34-positive human myeloid leukemia cell line: MHH225 growing in serum-free culture.

Authors:  H T Hassan; E Petershofen; E Lux; C Fonatsch; G Heil; M Freund
Journal:  Ann Hematol       Date:  1995-09       Impact factor: 3.673

Review 10.  Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls.

Authors:  Natalie E Duran; Daniel W Hommes
Journal:  Therap Adv Gastroenterol       Date:  2016-04-25       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.